Japan authorizes inter-pharmacy transfer of ADHD medication to address supply shortages

Japanese health authorities have authorized the transfer of ADHD medication, specifically Concerta, between pharmacies to mitigate supply-driven patient displacement. This policy shift aims to reduce the burden on patients forced to search multiple locations for stock, though the efficacy of the distribution network remains to be tested.